CDC Panel Backs Full Approval for Pfizer–BioNTech COVID-19 Vaccine for Over 16s

A vial of Pfizer–BioNTech COVID-19 vaccine is seen at a pop up vaccine clinic in the Arleta neighborhood of Los Angeles, California, Aug. 23, 2021. Robyn Beck/AFP via Getty Images

An advisory group of the Centers for Disease Control and Prevention (CDC) unanimously endorsed the full approval of the Pfizer–BioNTech COVID-19 Vaccine for U.S. citizens who are over the age of 16.

The Advisory on Immunization Practices (ACIP), a committee within the CDC, said on Monday that the vaccine by Pfizer–BioNTech against the CCP (Chinese Communist Party) virus is safe and effective for those aged 16 and older, and that the benefits of the Pfizer vaccine outweigh potential risks associated with the shots.